CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.

The federal government is rolling out a new program that will enable some Medicare recipients to access GLP-1 weight loss medications for $50 per month.  The U.S. Centers for Medicare and Medicaid Services launched the pilot program,

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what to watch next.

The Centers for Medicare and Medicaid Services (CMS) is launching a pilot program on July 1 to subsidize costs of GLP-1s prescribed for weight loss for eligible beneficiaries. Medicare historically prohibited coverage of drugs taken strictly for weight loss,

Medicare Part D is introducing important prescription drug cost updates in 2026, including higher deductibles, a new out-of-pocket cap, and expanded savings on selected medications that could significantly affect beneficiaries' healthcare budgets.